Stockscreener 앱 받기
10.25
12.02%
1.10
시간 외 거래:
10.25
전일 마감가:
$9.15
열려 있는:
$9.24
하루 거래량:
221.41K
Relative Volume:
0.40
시가총액:
$27.78M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+12.95%
1개월 성능:
+64.26%
6개월 성능:
+98.64%
1년 성능:
+0.00%
1일 변동 폭
$9.24
$10.37
1주일 범위
$7.961
$10.37
52주 변동 폭
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
명칭
Quantum Biopharma Ltd
전화
-
주소
-
QNTM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
10.25 | 2.61M | 0 | 0 | 0 | 0.00 |
|
HLN
Haleon Plc Adr
|
10.80 | 47.63B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
163.04 | 71.99B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.85 | 3.50M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.11 | 44.91B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.94 | 20.73B | 16.54B | -1.64B | 749.00M | -1.45 |
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
Quantum BioPharma to Present at Upcoming Investor Conferences - TipRanks
Cathie Wood Is Betting Big on This Hidden-Gem AI Stock - The Globe and Mail
Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference - GlobeNewswire
Quantum BioPharma Sets Double Conference Appearance: Key Investor Presentations Coming This May - Stock Titan
Prediction: MercadoLibre Will Beat the Market. Here's Why. - The Globe and Mail
TORONTO TEMPO MARKS ONE YEAR TO TIP-OFF WITH IMMERSIVE TEMPO LIVE EVENT - The Globe and Mail
Quantum Biopharma reports Q1 2025 financials - Investing.com
Quantum Biopharma reports Q1 2025 financials By Investing.com - Investing.com Nigeria
Quantum Biopharma Reports Q1 2025 Financial Results - TipRanks
Quantum BioPharma (QNTM) Completes Key Studies for Multiple Scle - GuruFocus
Quantum BioPharma Completes Key Studies for MS Drug Lucid-MS - TipRanks
Quantum BioPharma Completes Dosing in 90-Day Toxicity Studies for Multiple Sclerosis Drug Lucid-21-302, Advancing Toward IND Submission - Nasdaq
Quantum BioPharma Announces Completion of Dosing in 90-Day - GlobeNewswire
Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis - Welland Tribune
Quantum BioPharma Ltd. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:QNTM) - Seeking Alpha
Quantum Biopharma Files Amended Complaint Against CIBC - GlobeNewswire
Quantum BioPharma (QNTM) Files Amended Complaint Over Alleged Ma - GuruFocus
Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - The Manila Times
Atlassian Q3 Earnings Surpass Expectations, Revenues Rise Y/Y - The Globe and Mail
Quantum Biopharma Ltd. Approved to Dual List on Upstream - ACCESS Newswire
Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Quantum BioPharma to Reveal Year-End Results and Key Regulatory Milestones in May 6 Update - Stock Titan
Quantum BioPharma Ltd. to Host Business Update Conference Call on May 6, 2025 - Nasdaq
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time - GlobeNewswire
Quantum BioPharma adds Kevin Malone as advisor - Investing.com Australia
Quantum BioPharma adds Kevin Malone as advisor By Investing.com - Investing.com South Africa
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor - The Manila Times
Quantum Biopharma Announces Advocate Against Naked Short - GlobeNewswire
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin ... - Bluefield Daily Telegraph
Quantum BioPharma Strengthens Defense: Short Selling Expert Kevin Malone to Combat Market Manipulation - Stock Titan
Quantum BioPharma Announces RSU Grant and Debt Settlement - TipRanks
Quantum BioPharma Corporate Update - Newsfile
1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ - The Globe and Mail
West Fraser Timber Ltd Stock Analysis: Q1 2025 Earnings and Future Outlook - The Globe and Mail
Meta Platforms (META) Can Withstand an Advertising Slowdown, Says Citigroup - The Globe and Mail
Stocks Pressured by Fears of a Tariff-Induced Slowdown - The Globe and Mail
Why ServiceNow Stock Is Gaining Today - The Globe and Mail
What to Know About Jeff Bezos’ Secret EV Startup Slate Auto - The Globe and Mail
Allied Announces April 2025 Distribution - The Globe and Mail
Rocket Lab Stock (RKLB) Soars on Major Hypersonic Tech Deals with US and UK Governments - The Globe and Mail
Abbott Laboratories (ABT) Q1 Earnings: What To Expect - The Globe and Mail
BWXT Moving Forward to Support National Security, Domestic Uranium Enrichment Mission - The Globe and Mail
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhar - GuruFocus
Quantum BioPharma (QNTM) Prevails in Legal Dispute with Former C - GuruFocus
Lithium Argentina to Release First Quarter 2025 Results on May 14, 2025 - The Globe and Mail
Quantum BioPharma wins legal battle against former CEO By Investing.com - Investing.com South Africa
Market Analysis: April 14th, 2025 - The Globe and Mail
Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold - The Globe and Mail
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Canadian Insurance Market Remains Strong Amidst Market Volatility: Aon Report - The Globe and Mail
Quantum Biopharma Ltd (QNTM) 재무 분석
Quantum Biopharma Ltd (QNTM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.57%
자본화:
|
볼륨(24시간):